Top 10 Companies Leading the HLA Typing Market

 

The HLA Typing Market is poised for robust expansion, projected to grow at an impressive CAGR of 5.6% from 2022 to 2029, according to the latest report by Meticulous Research. This forecast places the market's value at a substantial $1.9 billion by 2029. The HLA Typing Market encompasses a comprehensive array of offerings, including consumables, instruments, software, and services. This remarkable growth can be attributed to the rising number of organ transplantation procedures and the continuous technological advancements in molecular assays for HLA typing. Furthermore, increasing awareness about the significance of organ donation is anticipated to create significant opportunities for market expansion.

Here are the leading organizations shaping the HLA Typing Market: https://meticulousblog.org/top-10-companies-in-hla-typing-market/

1. Becton, Dickinson and Company (BD) (U.S.)

Founded in 1897 and headquartered in New Jersey, U.S., Becton, Dickinson and Company (BD) is a distinguished player in the field. BD specializes in the development, manufacturing, and distribution of a diverse range of medical devices, supplies, laboratory equipment, and diagnostic products. The company's operations are categorized into three key segments: BD Medical, BD Life Sciences, and BD Interventional. In the HLA typing market, BD stands out through its Biosciences unit, offering HLA antibodies and immunofluorescence test kits designed for HLA antigen detection. BD boasts a global manufacturing presence with facilities spanning across multiple countries.

2. Thermo Fisher Scientific Inc. (U.S.)

Thermo Fisher Scientific, established in 2006 and headquartered in Massachusetts, U.S., is a renowned biotechnology enterprise dedicated to life sciences research, diagnostic enhancements, and laboratory efficiency improvement. The company operates through four distinct business segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. Within the HLA typing market, Thermo Fisher plays a pivotal role through its Transplant Diagnostics business, offering a wide array of HLA typing and antibody detection assays. These assays employ cutting-edge technologies such as serological, molecular, enzyme-linked immunosorbent assays (ELISA), flow cytometry, and multiplexing technologies.

3. Illumina, Inc. (U.S.)

Illumina, founded in 1998 and headquartered in California, U.S., is a global leader in developing, manufacturing, and marketing life sciences tools and integrated systems tailored for gene analysis. The company provides integrated sequencing and microarray systems, consumables, genetic and genomic analysis tools, and operates through Core Illumina and GRAIL business segments. Within the HLA typing market, Illumina's Core Illumina segment offers Next Generation Sequencing (NGS) based assays and HLA analysis software.

4. CareDx, Inc. (U.S.)

Established in 1998 and headquartered in California, U.S., CareDx focuses on discovering, developing, and commercializing diagnostic solutions designed to benefit transplant patients and caregivers. The company offers its products through three principal business segments: Testing Services, Products, and Patient and Digital Solutions, all of which encompass HLA typing solutions. CareDx provides diagnostic surveillance services, manufactures transplantation-related products, and offers digital solutions linked to transplantation.

5. Genome Diagnostics B.V. (GenDx) (Netherlands)

GenDx, founded in 2005 and headquartered in Utrecht, Netherlands, is a leading molecular diagnostics and HLA typing specialist. The company offers diagnostic tests, services, software, educational products, and custom lab services in HLA typing, chimerism monitoring, next-generation sequencing (NGS) for killer cell immunoglobulin-like receptor typing (NGS-KIR), and more. GenDx operates globally through its network of distributors and has manufacturing and R&D facilities in the Netherlands.

6. Bio-Rad Laboratories, Inc. (U.S.)

Bio-Rad Laboratories, founded in 1952 and headquartered in the U.S., is a prominent manufacturer and distributor of life science research and clinical diagnostics products and systems. The company operates through two business segments: Life Science and Clinical Diagnostics. Within the HLA typing market, Bio-Rad contributes significantly through its Clinical Diagnostics segment, offering test systems, informatics systems, test kits, and specialized quality controls.

7. Immucor Inc. (U.S.)

Founded in 1982 and headquartered in Georgia, U.S., Immucor Inc. specializes in providing transfusion and transplantation diagnostic products, including HLA typing products, antibody products, and analyzers. The company caters to HLA clinical labs, research labs, and registry labs, offering a comprehensive range of HLA typing solutions.

8. TBG Diagnostics Limited (TDL) (Australia)

Established in 1989 and headquartered in Queensland, Australia, TDL is a molecular diagnostics company focused on developing and manufacturing diagnostic kits, instruments, and services. TDL offers HLA typing solutions, including HLA sequence-specific primer (SSP) typing kits, HLA sequence-based typing (SBT) kits, and HLA real-time PCR typing kits, as well as HLA typing services through its certified laboratory.

9. BAG Diagnostics GmbH (Germany)

Founded in 1947 and based in Hesse, Germany, BAG Diagnostics specializes in HLA and blood diagnostics. The company offers transplant diagnostics, transfusion diagnostics, human genetics, and automation products within the HLA typing market through its Transplant Diagnostics segment.

10. QIAGEN N.V. (Netherlands)

QIAGEN, established in 1984 and headquartered in Venlo, Netherlands, is a leading provider of samples and assays for DNA, RNA, and protein extraction, purification, amplification, and interpretation. The company offers a wide range of kits, systems, and software in the HLA typing market, operating across multiple countries through its subsidiaries.

For further insights into these companies, including financial performance, key products, significant strategies, partnerships, and acquisitions, consult Meticulous Research's comprehensive report on the HLA Typing Market. This report provides detailed market size estimates, market share analysis, revenue figures, and coverage of key industry trends and issues.

Top 10 Companies Leading the HLA Typing Market: https://meticulousblog.org/top-10-companies-in-hla-typing-market/

About Meticulous Research®

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze and present the critical market data with great attention to details.

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions.

With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research